Ratings Synthomer plc

Equities

SYNT

GB00BNTVWJ75

Market Closed - London S.E. 16:35:27 19/07/2024 BST 5-day change 1st Jan Change
267 GBX -4.81% Intraday chart for Synthomer plc -2.73% +40.75%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.49 for the 2024 fiscal year.
  • The company appears to be poorly valued given its net asset value.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
+40.75% 564M
B
+22.60% 69.44B
A-
-4.17% 47.36B
A-
+21.50% 43.96B
B+
+35.18% 29.21B
A-
+6.31% 19.06B
C+
+12.45% 17.05B
B+
-10.63% 15.17B
B+
-28.41% 14.33B
A-
+28.44% 12.08B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes